State Street Corp Geron Corp Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Geron Corp stock. As of the latest transaction made, State Street Corp holds 28,961,671 shares of GERN stock, worth $116 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,961,671

Previous 22,548,467 28.44%

Holding current value

$116 Million

Previous $95.6 Million 37.53%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $26.7 Million - $32 Million	6,413,204 Added 28.44%	28,961,671 $131 Million
Q2 2024 Aug 14, 2024	SELL	$3.1 - $5.09 $28.1 Million - $46.1 Million	-9,055,925 Reduced 28.65%	22,548,467 $95.6 Million
Q1 2024 May 15, 2024	BUY	$1.75 - $3.44 $10.5 Million - $20.6 Million	5,978,786 Added 23.33%	31,604,392 $104 Million
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $442,344 - $587,250	254,221 Added 1.0%	25,625,606 $54.1 Million
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $8.64 Million - $13.4 Million	4,093,323 Added 19.24%	25,371,385 $53.8 Million
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $8.43 Million - $15.8 Million	-4,279,539 Reduced 16.74%	21,278,062 $68.3 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $12.5 Million - $19.9 Million	5,845,412 Added 29.65%	25,557,601 $55.5 Million
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $12.6 Million - $15 Million	6,204,477 Added 45.93%	19,712,189 $47.7 Million
Q3 2022 Nov 15, 2022	SELL	$1.67 - $2.94 $13,699 - $24,116	-8,203 Reduced 0.06%	13,507,712 $31.6 Million
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.65 $3,492 - $4,842	-2,935 Reduced 0.02%	13,515,915 $21 Million
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $1.58 Million - $2.55 Million	1,593,868 Added 13.37%	13,518,850 $18.4 Million
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $1.23 Million - $1.73 Million	-1,004,475 Reduced 7.77%	11,924,982 $14.5 Million
Q3 2021 Nov 15, 2021	SELL	$1.2 - $1.5 $815,114 - $1.02 Million	-679,262 Reduced 4.99%	12,929,457 $17.7 Million
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $3.77 Million - $5.52 Million	-3,015,661 Reduced 18.14%	13,608,719 $19.2 Million
Q1 2021 May 17, 2021	BUY	$1.52 - $2.1 $4.66 Million - $6.44 Million	3,067,221 Added 22.62%	16,624,380 $26.3 Million
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $2.96 Million - $3.91 Million	1,909,521 Added 16.39%	13,557,159 $21.6 Million
Q3 2020 Nov 10, 2020	BUY	$1.59 - $2.19 $12.1 Million - $16.7 Million	7,640,921 Added 190.7%	11,647,638 $20.3 Million
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $287,282 - $596,452	273,602 Added 7.33%	4,006,717 $8.74 Million
Q1 2020 May 11, 2020	BUY	$0.89 - $1.49 $3.32 Million - $5.56 Million	3,733,115 New	3,733,115 $4.44 Million

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Geron Corp Transaction History